Hyperfine (HYPR) EBITDA (2021 - 2026)
Hyperfine (HYPR) posted EBITDA of -$8.6 million for Q1 2026, down 11.61% on a QoQ basis from -$7.7 million in Q4 2025, and up 21.5% year-over-year from -$7.0 million in Q1 2025.
Hyperfine (HYPR) EBITDA (2021 - 2026) Analysis & Trends
Hyperfine's EBITDA history runs 6 years deep, the most recent figure standing at -$8.6 million for Q1 2026.
- Quarterly EBITDA rose 21.5% year-over-year to -$8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$34.7 million (up 20.09% YoY) and the FY2025 annual result came in at -$37.1 million, up 14.2% from the prior year.
- EBITDA was -$8.6 million for Q1 2026 at Hyperfine, down from -$7.7 million in the prior quarter.
- Across five years, EBITDA topped out at -$7.7 million in Q4 2025 and bottomed at -$23.8 million in Q1 2022.
- A 5-year average of -$12.4 million and a median of -$11.0 million in 2024 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA sank 204.56% — and 2023, when it soared 49.59%.
- Hyperfine's EBITDA stood at -$13.6 million in 2022, then climbed by 14.67% to -$11.6 million in 2023, then rose by 7.43% to -$10.8 million in 2024, then climbed by 28.77% to -$7.7 million in 2025, then declined by 11.61% to -$8.6 million in 2026.
- Business Quant data shows HYPR's EBITDA at -$8.6 million in Q1 2026, -$7.7 million in Q4 2025, and -$8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | -8.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.56 Mn |
| Dec 31, 2025 | -7.67 Mn |
| Sep 30, 2025 | -8.92 Mn |
| Jun 30, 2025 | -9.60 Mn |
| Mar 31, 2025 | -10.90 Mn |
| Dec 31, 2024 | -10.77 Mn |
| Sep 30, 2024 | -10.96 Mn |
| Jun 30, 2024 | -10.85 Mn |
| Mar 31, 2024 | -10.65 Mn |
| Dec 31, 2023 | -11.63 Mn |
| Sep 30, 2023 | -11.76 Mn |
| Jun 30, 2023 | -11.69 Mn |
| Mar 31, 2023 | -13.04 Mn |
| Dec 31, 2022 | -13.63 Mn |
| Sep 30, 2022 | -13.28 Mn |
| Jun 30, 2022 | -23.19 Mn |
| Mar 31, 2022 | -23.77 Mn |
| Dec 31, 2021 | -26.09 Mn |
| Sep 30, 2021 | -16.39 Mn |
| Jun 30, 2021 | -14.59 Mn |